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Abstract: We aimed to assess if the same cognitive batteries can be used cross-nationally to monitor
the effect of Phenylketonuria (PKU). We assessed whether a battery, previously used with English
adults with PKU (AwPKU), was also sensitive to impairments in Italian AwPKU. From our original
battery, we selected a number of tasks that comprehensively assessed visual attention, visuo-motor
coordination, executive functions (particularly, reasoning, planning, and monitoring), sustained
attention, and verbal and visual memory and learning. When verbal stimuli/or responses were
involved, stimuli were closely matched between the two languages for psycholinguistic variables.
We administered the tasks to 19 Italian AwPKU and 19 Italian matched controls and compared results
from with 19 English AwPKU and 19 English matched controls selected from a previously tested
cohort. Participant election was blind to cognitive performance and metabolic control, but participants
were closely matched for age and education. The Italian AwPKU group had slightly worse metabolic
control but showed levels of performance and patterns of impairment similar to the English AwPKU
group. The Italian results also showed extensive correlations between adult cognitive measures
and metabolic measures across the life span, both in terms of Phenylalanine (Phe) levels and Phe
fluctuations, replicating previous results in English. These results suggest that batteries with the same
and/or matched tasks can be used to assess cognitive outcomes across countries allowing results to
be compared and accrued. Future studies should explore potential differences in metabolic control
across countries to understand what variables make metabolic control easier to achieve.
Keywords: PKU; cognitive outcomes; cross-cultural; cross-countries; Phe associations
1. Introduction
Phenylketonuria (PKU) is an inherited metabolic disease occurring in about 1/10,000 live births
where an error in the gene coding for the enzyme phenylalanine hydroxylase (PAH) produces an
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inability to metabolize the amino acid phenylalanine (Phe) into tyrosine with serious consequences
for brain health [1]. Tremendous advances have been made in our understanding and treatment of
this disorder from the 1930s when it was first discovered by a Norwegian physician, Asbjørn Følling,
who noticed high levels of phenylpyruvic acid in the urine of some patients with severe mental disability
and established connections with high levels of Phe in the blood. Since the wide-spread introduction
of new-born screening in the late seventies in most countries, infants with PKU follow a Phe-restricted
diet which lowers blood Phe levels and eliminates mental disability. It is now recommended that a
PKU diet is followed throughout life. Current European guidelines recommend Phe to be kept within
the target range of 120–360 µmol/L till 12 years of age and within 120–600 µmol/L, above 12 years [2,3].
American guidelines recommend a target range of 120–360 µmol/L throughout life (American College
of Medical Genetics and Genomics, ACMG) [4]. In classical PKU, without treatment, Phe could
exceed >2000 µmol/L.
Maintaining a Phe-restricted diet allows people with PKU to lead normal lives. However, not all
is well. The PKU diet is expensive, unpalatable, and unsociable. Thus, it is often self-relaxed in
late childhood and abandoned during late adolescence [5–9]. Possibly because Phe levels remain
suboptimal, on average, people with PKU do not reach their full cognitive potentials [7]. IQ is in the
normal range, but lower than matched controls [10], and there are impairments in cognitive tasks,
especially when speed of processing and higher cognitive functions are involved [11–16]. Moreover,
this is the first generation of early treated adults with PKU (from now on AwPKU) to reach middle-age
and we do not know the effects of prolonged high levels of Phe on aging brains.
Better management of PKU may be achieved with the wider use of existing pharmacological
treatments [3,17,18] and the introduction of new ones [19–21], but it also depends on a better
understanding of how the cognitive impairments experienced by this population relate to levels and
variations in Phe levels across the life span. While Phe may be particularly toxic for developing brains,
we need evidence of the safety of accumulating high Phe levels on aging brains. Finally, it is important
to understand whether some individuals are less affected by high Phe since there is some evidence
of individual variation [6,22–24]. For a few people with PKU, it may be less important to keep on a
strict diet.
Establishing the efficacy of new treatments and the safety of existing ones relies on the
comprehensive cognitive assessments of large samples of people with PKU and relative controls.
Ideally, cognition should be tested across the board because the effects of Phe may vary for different
cognitive functions. Moreover, it is important to use multiple measures to increase reliability since
tasks do not tap cognitive function in a simple, univocal way. However, this is time-consuming and
recruiting participants is challenging since PKU is a rare disease. These difficulties, compounded by
resource limitations, mean that it is difficult for studies based on single clinical centres to achieve the
desired breadth and depth of testing with enough power [15,16,25] making the ability to collate results
across national and international centres particularly important. However, there is a lack of studies
comparing results across national samples.
Similar negative effects of PKU on cognition have already been reported across countries
(for example, deficits in executive functions have been reported in: Italy: Nardecchia et al. [26];
the Netherlands: Jahja et al. [27]; the UK: Palermo et al. [15]; the USA: Brumm et al. [25]; Christ, et al. [28];
Diamond et al. [2]; deficits of speed of processing have been reported in Australia: Moyle et al. [10];
Germany: Feldmann et al. [29]; the UK: Channon et al. [30]; Palermo et al. [15]; the USA: Janos et al. [31]).
These results suggest that the effects of Phe on cognition are similar across countries, in spite of cultural
and environmental differences in the approach to food and feeding. However, there is a lack of studies
directly comparing results collected using the same tests and direct comparisons are important to give
us confidence that results can be accrued.
The objectives of the present study are twofold: 1. we aim to replicate results previously obtained
with a relatively large sample of English AwPKU (N = 37) [5,6,15,32] by administering a subset of
tasks to a new sample of Italian patients; 2. we aim to demonstrate that the same tasks which are
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sensitive to blood Phe in English are also sensitive in Italian so that they also demonstrate impairments
and relationships with blood Phe levels and Phe fluctuations throughout the lifespan. A comparison
between English and Italian PKU samples is particularly relevant given differences in the approach to
food and diet in the two countries. Note that there is no issue of validity and specificity in the cognitive
assessment of PKU. We do not need to distinguish people with PKU from healthy people. Genetic
tests reliably establish the presence/absence of PKU from birth and high-level of Phe are constant in
people of PKU if the disease is untreated. What is important, instead, is test-sensitivity to variations in
metabolic control so that cognitive outcomes can be properly monitored. This can be demonstrated by
showing impairment compared to healthy controls and correlations with metabolic measures.
We assessed metabolic control and cognitive outcomes in 19 Italian early-treated AwPKU and
19 matched controls and compared performance with that of 19 English early-treated AwPKU and
relative controls selected from our previously tested cohort [15]. All groups were matched for age and
education. Comparisons between PKU groups were in terms of z scores which considered performance
in terms of deviations from the relative control groups. In addition, we assessed the sensitivity of
our cognitive battery in Italian by assessing correlations with current and historical blood Phe levels.
The Italian and English testing batteries were matched as rigorously as possible. In most cases, our tests
were exactly the same (the same materials and procedure); those with verbal stimuli were carefully
matched for psycholinguistic variables such as word frequency and word length (e.g., Rey AVLT).
Similar levels of impairments and similar correlations with Phe levels will demonstrate test reliability
and sensitivity for different national PKU samples. It will also give us confidence that, when the same
or matched tasks are used, results can be accrued, allowing more power for analyses.
2. Method
2.1. Participants
All PKU participants were adults diagnosed soon after birth (2–3 days in Italy and 5–7 days in
the UK).
Nineteen Italian AwPKU were recruited from the Clinical Centre for Neurometabolic Diseases
in the Department of Human Neuroscience, Child Neurology and Psychiatry Unit at the Sapienza
University of Rome. Three participants were currently treated with sapropterin. Nineteen Italian
control participants were recruited among students and friends of the researchers. They were matched
to the Italian PKU participants for age and education. Among the Italian participants, 4 had a diagnostic
blood Phe level > 600 µmol/L but <1200 µmol/L; 15 participants had Phe > 1200 µmol/L at birth.
To allow a direct comparison between an Italian and an English sample, 19 English AwPKU
were selected from a larger sample of 37 AwPKU previously tested [15,16,32]. They were all tested
at the Inherited Metabolic Disease Unit at the Queen Elizabeth Hospital in Birmingham. They all
had Phe > 1200 µmol/L at birth. They were matched one-to-one with the Italian AwPKU for gender,
age, and education. Matching was blind to cognitive performance and metabolic control as possible
differences were assessed. Thirty English healthy controls were originally recruited through an
advertising volunteering website. From this sample, we blindly selected 19 healthy controls matching
the English PKU participants for age and education (in number of years).
Power calculations indicated that 20 participants were necessary in the clinical group and
20 participants in the control group for a one tail effect size of 0.8 (consistent with what we found in our
previous studies) and =0.05, power (1-error probability) = 0.80. All AwPKU treated in the English and
Italian centres were invited to participate and were accepted in the study on a first-come, first-served
basis. Recruitment stopped when enough participants were tested. After the Italian PKU participants
were contacted, one participant became unavailable and we were left with 19 participants, which still
gave our study acceptable power (=0.78).
The English study received NHS ethical approval. The Italian study was approved by the local
ethics committee. All participants provided informed consent to the study.
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2.2. Ethical Approval
The study was conducted in accordance with the Declaration of Helsinki. All participants gave
their informed consent for inclusion before they participated in the study. In the UK, the protocol
was approved by the West Midlands NHS Ethics Committee (rec REC: 10/H1207/115). In Italy
the protocol was approved by the Institutional Review Board of “Sapienza”—University of Rome
(Project identification code 3629).
2.3. Metabolic Measures
For both the English and the Italian participants, metabolic measures were taken regularly since
birth and extensive records were available. The number of measures did not differ between countries
(see Table 1). Blood Phe monitoring was performed on dry blood spot collected after overnight fasting
by High Performace Liquid Chromatography until 2010 and then via tandem mass spectroscopy.
The laboratories of both centres have adhered and contributed to international quality control systems
Table 1. Demographic Variables in Terms of Age, Gender, Years of Education and Metabolic Control
across Ages for the Two Matched Groups of Italian and English AwPKU. Blood Phe measured in µmol/L.
Italian
AwPKU
English
AwPKU
English vs.
Italian
N = 19 N = 19 p Value
Mean SD Mean SD
Age 25.4 (range:19–33) 4.1
25.3 (range:
18–36) 6.1 n.s.
Education (in years) 14 1.8 14.6 1.9 n.s.
Gender (M/F) 8//11 8//11
Verbal IQ 98.8 12.9 100.4 8.9 n.s.
Performance IQ 99.3 15 103.3 12.9 n.s.
Full IQ 98.9 14.5 102.1 10.4 n.s.
Childhood (0–10 years)
Phe Average Median 499 149 386 168 p = 0.04
Phe Fluctuation 227 63 198 50 n.s.
Mean N observationsper
participant 208 79 259 156 n.s.
Adolescence (11–16 years)
Phe Average Median 702 194 612 293 n.s.
Phe Fluctuation 170 51 165 34 n.s.
Mean N obs. per participant 77 54 98 74 n.s.
Adulthood (17 years +)
Phe Average Median 970 239 733 344 p = 0.02
Phe Variation 217 65 122 41 p < 0.001
Mean N obs. per participant 58 49 62 58 n.s.
Lifetime
Phe Average Median 695 198 516 233 p = 0.02
Phe Fluctuation (SD) 208 46 171 33 p < 0.01
Mean N observations. per
participant 344 149 419 232 n.s.
Current Phe 1042 428 677 382 p = 0.01
Range 454–2081 65–1465
We averaged metabolic control in three age bands: childhood: 0–10 years old, adolescence:
11–16 years old, and adulthood: 17 years to present. We have also averaged measures throughout the
life-time and considered current Phe levels. For the Italian group, current Phe has been measured
immediately before the testing session/s or in the preceding few days; for the UK group, current Phe
has been measured immediately before the two testing sessions and averaged. We considered two
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types of measures: Phe level and Phe fluctuation/variation (we will use the term fluctuation from now).
Phe level in each band was calculated by taking the median values for each year and then averaging
the year values; Phe fluctuation was calculated by taking the SD for each year and then averaging year
values in the band.
2.4. Cognitive Assessment
Cognitive assessments were carried out in a quiet room at the clinical centres in Birmingham
and Rome. The testing session for the Italian participants lasted between 2 and 3 h. The English
participants carried out more tests and were tested in two separate sessions of similar length. Testing
was carried out by a psychologist or a neuropsychiatrist with neuropsychological training.
IQ was measured, for the Italian participants, using the Wechsler Adult Intelligence Scale-Revised
(WAIS-R) [33] and, for the English participants, the Wechsler abbreviated scale of intelligence (WASI) [34],
which includes the following subtests: Vocabulary, Block Design, Similarities, and Matrix Reasoning.
The WAIS-R and the WASI are strongly correlated providing similar validated measures of Full
Scale IQ [35]. In addition, participants were given a set of tasks chosen from the larger set of
tasks administered in our previous studies [15,16]. We chose tests which either showed a strong
difference between PKU participants and controls and/or strong correlations with metabolic measures.
We also prioritized tasks with non-linguistic stimuli which did not need adapting across languages.
Therefore, we did not include tests of picture naming, reading, spelling, and orthographic knowledge
(spoonerisms, phoneme deletions) where speed impairments could be due to a general reduction in
speed of processing which was also tapped by visual search. In addition, we did not include tasks
where relationship with metabolic measures are modest or absent [5]. Finally, to reduce the number
of tasks tapping similar functions, we also did not administer the Tower of Hanoi, lexical learning
task, the Stroop, and nonword repetition. Measures of short-term memory (digit span and Corsi span)
and a baseline measure of peripheral speed of processing were included for completeness and to
confirm or disprove impairments, given mixed results from the literature (for impairments in digit
span and nonword repetition see Palermo et al. [15]; for contrasting results see Brumm et al. [25],
and Moyle et al. [10]; see also Jahja et al. [27] for deficits with increasing working memory load).
The following cognitive areas were assessed:
2.4.1. Visual Attention
This was assessed with four tasks [15,16]: 1. Simple Detection: Press a response button as soon as
a ladybird appears on the screen; 2. Detection with Distractors: Press a button whenever a ladybird
appears on the screen alone or with a green bug, in the second part of the task the instruction was
changed to press a button whenever a green bug appeared on the screen alone or with a ladybird;
3. Feature Search: Detect a target among distractors not sharing features by pressing a “yes” or
“no” button (e.g., a red ladybird among green bugs); 4. Conjunction Search: Detect a target among
distractors sharing features (e.g., red ladybird among red bugs and green bugs). Both reaction times
(RT from now on) and accuracy measures (error rates) were taken.
2.4.2. Visuo-Motor Coordination
This was assessed with two tasks: 1. Grooved Pegboard Test [36]: Put pegs into the holes of a
board using only one hand as quickly as possible (short version with two trials one with the dominant
and one with the non-dominant hand for the Italian and English matched samples) and 2. Digit Symbol
Task [33]: Fill as many boxes as possible with symbols corresponding to numbers (key with associations
remains visible) in 90 s. Trail Making Test A (TMT A) [37,38]: connect circles containing numbers in
ascending order of the numbers as quickly as possible.
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2.4.3. Complex Executive Functions
This was assessed with four tasks tapping skills such as planning, flexibility, and abstract thinking:
1. The Wisconsin Card Sorting Test (WCST) 64 card version [39]: Discover the rules to match cards
from a deck with four reference cards according to the shape, number or colour of the symbols on the
card; feedback is provided to allow learning. Flexibility is required when the sorting rule is changed
unknown to the participant and the new rule must be discovered. We used three different scores: total
errors, number of perseverative responses and number of completed categories. 2. Difference in speed
between Trail Making Test B-A (TMT B-A) [37,38]. A involves connecting circles containing numbers
in ascending order; B also involves connecting circles in ascending order but alternating between the
number and letters contained in the circles. Only time is considered in this test; when occasionally an
error is made, it is corrected by the examiner and this affects the time to complete the task. 3 Fluency:
For letter fluency: generate as many words as possible starting with a given letter in a minute of time
(for Italian: P, F and L; Novelli et al. [40] for English: C, F and L; Benton et al. [41]); for semantic
fluency [42,43]: generate as many names of animals as possible in 1 min of time. This requires planning
an efficient search through the lexicon.
2.4.4. Short-term Memory/Working Memory
This was assessed with two tasks: 1. Digit Span: Repeat a sequence of digits spoken by the
examiner soon after presentation; 2. Corsi Block Tapping Test [44]: The examiner taps a sequence of
blocks and the participant must reproduce the sequence in the same order. Span was calculated as the
longest sequence which could be repeated correctly (1 point was awarded for each length if all trials
are correct; otherwise a corresponding fraction of point was awarded; for digit span where sequences
started from length four, sequences of length 1–3 were assumed all correct, unless there were errors
with sequences of four digits; in this case, sequences of shorter length were presented).
2.4.5. Sustained Attention
This was assessed with the Rapid Visual Information Processing task (RVP) [45]: detect three
target sequences of three digits by pressing the response key when the last number of the sequence
appears on the screen. Scores are percentage correct.
2.4.6. Verbal Memory and Learning
This was assessed with The Rey Auditory Verbal Learning Test [46,47] which asks for learning,
immediate recall, and delayed recall of a list of 15 words. The list is presented five times and participants
are asked to recall the words immediately after each presentation. After the 5th presentation (A5),
an interfering list (B1) is presented and participants are asked to recall this list and then, once again,
the original list (A6) without a further presentation. Finally, participants are asked to recall the original
list after a 20-min filled interval. Our scores include total number of errors across the five learning
trials (A1-5); errors in recalling the words after an interfering list (A6); and, again, errors in delayed
recall of the original list.
2.4.7. Visual Memory and Learning
This was assessed with the Paired Associates Visual Learning [48]: Learn to associate objects with
locations. Z scores for each participant for each task were computed using the relevant control group
as a reference point. As well as considering performance in individual tasks, for each participant,
we computed two indexes of overall cognitive performance: 1. We averaged z scores in all tasks and
2. We considered the rate of poor scores across all tasks (rate of Z scores => 1.5); this second index
is important since an average Z score may mask significant areas of difficulties in a number of tasks
(given a profile were some skills are good and others are impaired).
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3. Data Analyses
We used two-tailed t-tests to compare the demographics and metabolic measures of the Italian and
English AwPKU, as well as to compare the demographics and cognitive performance of each of these
clinical groups with the corresponding control group. This allowed us to assess whether the Italian
AwPKU demonstrated similar impairments to the English AwPKU [15]. Additionally, we computed Z
scores for each PKU participant and each task, using the corresponding control group (subtracting
each test value from the corresponding control mean and dividing by the control SD). Average Z scores
for Italian and English AwPKU were analyzed using two-tailed t-tests to compare size of standardized
effects. For this and all other analyses in the paper, we were more interested in comparing patterns
across groups than in the significance of an individual measure. However, with the t-tests, we have
indicated comparisons which remained significant after a Bonferroni correction.
To demonstrate that our battery is as sensitive to impairment in Italian as in English, we carried
out Person r correlations between all our cognitive measures and measures of metabolic control,
both current and historical. This resulted in a high overall number of correlations for each clinical
group (N = 144). Individually, each correlation is not very reliable since correlations are notoriously
unstable with a small N (19 participants). However, we were not interested in the significance of
individual correlations, but, instead, in establishing the sensitive of our tasks to metabolic controls in
Italian as in English, across measures. Considering patterns across a large number of cognitive tasks
and metabolic measures will reduce error and boost power. We used a χ2 s to assess the significance of
a positive/negative correlations ratio against a chance 50/50 ratio, which is expected if no true relation
exists between cognitive performance and metabolic control. In addition, we used a one-sample t-test
to assess whether the average correlation was significantly different from 0 (see Romani et al., [6] for a
similar methodology). We carried out these analyses on both Italian and English PKU samples.
4. Results
4.1. Demographics
Demographic and metabolic information for English and Italian PKU groups are shown in Table 1.
The Italian and English groups were matched for age, education, and gender. They did not differ
significantly for of any of these variables or for IQ. However, the average Phe level was higher in the
Italian group, with differences reaching significance for all age bands but adolescence. In addition,
Phe levels were more variable in the Italian than in the English group in adulthood and when measured
throughout the lifetime.
4.2. Cognitive Performance
4.2.1. AwPKU vs. Controls
Table 2 shows the performance of the Italian and English PKU groups compared to matched
samples of healthy controls. Results show that both Italian and English AwPKU were impaired in a
similar range of tasks with good overlap with the English PKU group.
Both Italian and English AwPKU were impaired in IQ measures and showed a reduced speed
in allocating visuo-spatial attention and good accuracy in visual search tasks. Both groups showed
impairments in tasks tapping visuo-motor coordination (but for the Italian group differences reached
significance only for the digit symbol test). The Italian group also showed impairments in the TMT b
and a-b and in the fluency tasks and in the RVP task. Both groups showed no difference in the WCST.
Finally, both groups performed well in verbal and visuo-spatial short-term memory tasks (digit span,
Corsi Block tapping test) and in tasks tapping learning and memory with only a marginal impairment
for the Italian AwPKU.
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Table 2. Cognitive Performance of Italian and English PKU Participants and Healthy Controls Matched for Age and Educations to the Respective Clinical Groups.
ITALIAN PARTICIPANTS (N = 19 In Each Group) ENGLISH PARTICIPANTS (N = 19 In Each Group)
AwPKU Controls Diff. AwPKU Controls Diff.
Mean SD Mean SD p Value Mean SD Mean SD p Value
Age 25.4 4.1 24.7 3.4 n.s. 25.3 6.1 24.4 5.35 n.s.
Education (in years) 14.0 1.8 13.9 1.7 n.s. 14.6 1.9 14.8 1.7 n.s.
Gender (M/F) 8//11 8//11 7//12 6//13
VIQ 98.8 13 108.5 13.1 0.03 100.4 8.9 109.6 9.6 <0.001 #
PIQ 99.3 15 107.1 9.6 0.07 103.3 12.9 110.2 12.6 n.s.
FIQ 98.9 15 110.1 12.0 0.01 102.1 10.4 111.1 10.3 0.01
VISUAL ATTENTION
Simple Detection (RT—ms) 325 46 315 44.6 n.s. 331 50.7 304.9 51.2 0.06
Detention with Distractors
RT—ms 483 104 430 58 0.02 433 56.4 392 54.2 0.03
% errors 0.8 0.6 0.5 1.1 n.s. 0.8 0.8 0.5 0.6 n.s.
Feature Search
RT—ms 752 262 586 113 0.02 581 111 492.3 70.5 0.01
% errors 1.6 4.7 0.6 1.2 n.s. 1.9 2.6 2.3 2.3 n.s.
Conjunction Search
RT—ms 1152 237 938 203 <0.001 # 998 162 846 129.0 <0.001 #
% errors 3.2 4.7 2.8 4.7 n.s. 2 2.2 3.5 5.4 n.s.
VISUO-MOTOR COORDINATION
Pegboard (Time–s) 76.7 11 70.6 9.0 0.06 71.9 9.9 66.0 6.1 0.03
Digit Symbol (%errors in 90 s) 41.6 12 39.4 9.1 <0.001 # 37.1 11.6 27.9 10.3 0.01
Trail-Making Test A (Time–s) 32.4 15 29.9 12.1 n.s. 24.0 7.0 20.2 3.7 0.04
EXECUTIVE FUNCTIONS
WCST
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Table 2. Cont.
ITALIAN PARTICIPANTS (N = 19 In Each Group) ENGLISH PARTICIPANTS (N = 19 In Each Group)
AwPKU Controls Diff. AwPKU Controls Diff.
Mean SD Mean SD p Value Mean SD Mean SD p Value
Total errors 13.6 6.9 13.6 5.3 n.s. 13.8 8.6 11.9 5.5 n.s.
Perseverative responses 7.0 3.1 7.8 3.3 n.s. 7.9 5.1 7.5 5.3 n.s.
N of Completed Categories 4.0 1.1 4.1 1.0 n.s. 3.9 1.2 4.3 0.9 n.s.
Trail-Making Test
B (sec) 79.8 34 54.4 19.7 0.01 42 10.8 43.2 16.0 n.s.
B–A (sec) 47.5 29 24.4 13.1 <0.001 # 18 8.0 22.9 14.3 n.s.
Verbal Fluency
Letter (correct answers) 39.0 11 47.5 9.3 0.01 36.3 11.6 40.5 15.0 n.s.
Semantic (correct answers) 20.1 4.8 23.5 3.6 0.02 21.6 5.8 25.1 5.0 0.06
Rey Auditory Verbal Learning
Retention after interference (% errors A6) 17.2 13 8.4 7.6 0.02 19.6 18.3 15.1 16.9 n.s.
SUSTAINED ATTENTION
RVP (% of errors) 24.2 12 15.9 9.6 0.03 16.8 9.5 13.2 9.4 n.s.
SHORT-TERM MEMORY
Digit span 5.9 0.9 5.9 1.1 n.s. 6.2 0.8 6.5 0.9 n.s.
Corsi Block span 5.9 1.0 5.0 1.1 0.01 5.3 0.8 5.6 0.9 n.s.
(opposite to
expected)
MEMORY and LEARNING
Rey Auditory Verbal Learning
Trial A1–A5 (% errors) 20.8 8.8 19.7 6.1 n.s. 24.5 11.4 21.7 9.3 n.s.
Delayed Recall (% errors) 10.2 11 4.9 7.0 0.08 18.6 18 14.7 14.8 n.s.
Paired Associate Visual learning (% errors) 2.3 2.2 1.2 1.3 0.07 2.5 3 1.8 1.8 n.s.
Italian and English PKU groups are also matched a-priori for age and education. Diff. = Difference. # = comparison which remains significant after Bonferroni correction.
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4.2.2. Italian AwPKU vs. English AwPKU
Table 3 compares standardized performance of Italian and English PKU groups. Despite their
worse metabolic control, the Italian group performed significantly worse than the English PKU group
in only a few tasks. They were worse on the TMT B and B-A and on letter-fluency, marginally
worse on list recall after interference (retention A6), but better on the Corsi Block span. Overall,
their performance was numerically worse in terms of average Z score, but this was not statistically
significant. When we co-varied concurrent Phe, only the differences in trail making test B-A and Corsi
span remained significant (p = 0.009 and p < 0.001); differences in Trail making B and letter fluency
were only marginally significant (p = 0.06 and p = 0.08).
A detailed comparison of results in visual search tasks highlights the similarity of patterns in the
Italian and English PKU groups. Figure 1 shows RTs in the different conditions. Errors were too few for
analysis. Across groups, RTs in feature search do not increase with the number of distractors. This is
because in this condition the target item “pops out” and a parallel search suffices for a correct answer
(generating a flat profile). Instead, across groups, there is a steep increase in RTs with the number
of distractors in conjunction search. This is consistent with the need to serially explore the distinct
locations of the display in this condition. Moreover, all groups show slower RTs with “No” rather than
“Yes” trials, especially in the conjunction search. This is also expected. To decide that an item is not
present you need to check all locations in the display; instead to find a target item, only half of the
locations need to be checked on average. The PKU groups show the same patterns of the controls,
but they are slower in all conditions.
Trials (F (1, 36) = 43.9; p < 0.001; ηp2 = 0.550). There were also a number of significant interactions:
task x distracters (F (2, 72) = 77.7; p < 0.001; ηp2 = 0.683), because responses were slower with more
distracters in the conjunction search, but not in the feature search; distracters x trial (F (2, 72) = 16.0;
p < 0.001; ηp2 = 0.307) because the effect of the number of distracters was more marked in the “no” than
the “yes” trials; task x trial (F (1, 36) = 64.8; p < 0.001; ηp2 = 0.643) because slower responses in the “no”
rather than the “yes” trials occurred in the conjunction search, but not in the feature search. Finally,
there was a three-way interaction: task x distracters x trial (F (2, 72) = 12.6; p < 0.001; ηp2 = 0.259)
because responses were slower with the number of distracters more in the “no” than the “yes” trials,
but only in the conjunction search. Crucially, however, there were no significant interactions within
the group.
When PKU participants are compared to controls, differences are constant in all conditions, except
in the conjoined task where the English PKU group shows increasing differences from controls with
number of distractors: a fanning-out pattern (distracters x group: F (2, 72) = 3.8; p = 0.03; ηp2). Instead,
differences from controls always remained stable in the Italian group (F (2, 72) = 0.25; p= 0.78). We will
comment on this difference in the General Discussion.
Finally, we want to highlight that, as reported for the English sample (Palermo et al., 2017),
the variability in cognitive performance in Italian PKU participants is striking. Five PKU participants
(26% of the sample) had a normal cognitive profile when compared to the control group (average Z score:
−0.2; −0.7−0.1; % z score =>1.5: 5.0; 0–8.3; expected 6.7%; Full IQ = 114; 104–124). These participants
had fast speed of processing while maintaining a good accuracy.
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Table 3. Cognitive Performance of English and Italian PKU Groups in Term of Z Score Computed from
Relative Control Groups Matched for Age, Gender, and Education.
Italian AwPK Z Score English AwPKU Z Score Diff.
DOMAIN/TASK Mean SD Mean SD p
IQ 1.0 1.0 0.9 1.0 n.s.
VISUO-SPATIAL ATTENTION RTs
Simple Detection—ms 0.2 1.0 0.5 1.0 n.s.
Detention with Distractors—ms 1.3 2.1 0.8 1.0 n.s.
Feature Search—ms 1.5 2.3 1.3 1.6 n.s.
Conjunction Search ms 1.1 1.2 1.2 1.2 n.s.
VISUAL ATTENTION accuracy
Detention with Distractors—% errors 0.2 0.6 0.5 1.3 n.s.
Feature Search—% errors 0.9 4.0 −0.2 1.1 n.s.
Conjunction Search—% errors 0.1 1.0 −0.3 0.4 n.s.
VISUO-MOTOR COORDINATION
Pegboard—s 0.7 1.2 1.0 1.6 n.s.
Digit Symbol—% errors in 90 s 0.2 1.3 0.9 1.1 n.s.
Trail-Making Test A—s 0.2 1.2 1.0 1.9 n.s.
EXECUTIVE FUNCTIONS
WCST
Total errors 0.0 1.3 0.3 1.5 n.s.
Perseverative responses −0.3 0.8 0.1 1.0 n.s.
N of Completed Categories 0.1 1.0 0.3 1.3 n.s.
Trail-Making Tests
B (s) 1.3 1.7 −0.1 0.7 <0.001#
B–A (s) 1.8 2.2 −0.3 0.6 <0.001#
Verbal Fluency
Letter (correct answers) 0.9 1.1 0.3 0.8 0.05
Semantic (correct answers) 1.0 1.3 0.7 1.2 n.s.
Rey Auditory Verbal Learning
Retention after interference (% errors
A6) 1.1 1.7 0.3 1.0 0.07
SUSTAINED ATTENTION
RVP (% of errors) 0.9 1.3 0.4 1.0 n.s.
SHORT-TERM MEMORY
Digit span 0.0 0.8 0.3 0.9 n.s.
Corsi Block span −0.8 0.9 0.3 0.9 <0.001#
LEARNING
Rey Auditory Verbal Learning Test
Trial A1–A5—% errors 0.2 1.4 0.3 1.2 n.s.
Delayed Recall—% errors 0.8 1.5 0.3 1.2 n.s.
Paired Associate Visual learning—%
err 0.9 1.7 0.4 1.7 n.s.
OVERALL Z SCORE excluding IQ
mean 0.59 0.42 n.s.
SD 0.76 0.58
Diff. = Difference. # = comparison which remains significant after Bonferroni correction.
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Figure 1. Performance of the UK and Italian PKU groups and relative control groups on the visual search tasks. Dist = distractors.
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4.3. Cognitive Outcomes in Relation to Metabolic Control
We ran Bivariate Pearson r correlations between metabolic measures taken at different times during
the life span and our adult cognitive measures. To reduce the number of variables per task, we only
run correlations for search tasks, with RT measures; for TMT, with the B–A condition; for the WCST,
with the total errors; and for the Rey, with total errors over 1–5 trials and with delay recall. Table 4
shows results for the Italian sample. Results for the larger sample of English AwPKU are reported
in Romani et al. [5]. We do not report correlations with the English matched sub-sample because
correlations with a small sample are notoriously unstable. Thus, results with a smaller sub-sample
may differ from the results obtained with a larger sample in potentially misleading ways. However,
to compare results for the two languages with samples of an equal size, we also report, with both PKU
samples, the % of positive correlations and the average correlation.
The Italian sample had widespread significant correlations with only a few tasks failing to show
any significant correlation with any metabolic measure (pegboard task, the semantic fluency task,
and the Rey test). Almost all correlation (91%) were positive (132/144; χ2 = 60.5; p <.001). The average
correlation across tasks was 0.29 (SD = 0.22), which was significantly different from 0 (one sample t-test
(142) = 17.0; p < 0.001). In the English matched sample (N = 19), 69% of correlations were positive
(99/144 = 69%; χ2 = 10.5; p < 0.001) and the average correlation was 0.12 (SD = 0.25; one sample t-test
(142) = 5.7; p < 0.001). Taken together, these results indicate that our tests are sensitive to the level of
metabolic control in both languages.
Considering the qualitative pattern of correlations in the Italian sample, a number of significant
features can be noted which replicate findings from the larger English sample [5]: 1. Adult cognitive
performance correlates with current Phe levels, but also with historical Phe records with significant
correlations across the life-span; 2. Cognitive performance correlates with metabolic measures in terms
of both average Phe levels and Phe fluctuations (average SD per year), this confirms the importance
of maintaining not only low average Phe levels, but also of being constant and of avoid Phe peaks;
3. There are interactions between type of function an age when metabolic control is measured: some
functions are more effected by childhood Phe measures than by current Phe levels (see visuo-attentional
speed). Other functions, instead, show as much of an association with current levels as with historical
measures (IQ, visuo-motor control, sustained attention, memory, and learning.
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Table 4. Correlations Between Phe Measures Across the Life-Span and Cognitive Performance in Different Domains for the Italian PKU Sample (N = 19).
VISUAL ATTENTION SPEED VISUO-MOTOR EF-MONITORING SUST. LEARNING AND MEMORY
ITALIAN
PKU FSIQ Simple Detection Feature Conj. Peg-Board Digit WCST TMT Digit Corsi Sem ATTENT Rey Rey
Paired
Ass.
PHE RT
With
distractors
RT
Search
RT
Search
RT Sec. Symbol
Total
err b–a Span Span Fluency RVP %
Words
a1–a5
Words
Delayed
Visual
Learning
0–10 yrs
Average 0.38 0.43 0.42 0.15 0.30 0.05 0.28 0.19 0.55 * 0.57 * 0.37 0.03 0.43 0.17 0.08 0.30
SD 0.31 0.73 ** 0.73 ** 0.34 0.49 * 0.02 0.13 −0.10 0.55 * 0.66 ** 0.42 0.08 0.57 * 0.34 0.25 0.36
11–16 yrs
Average 0.53 * 0.08 0.30 0.41 0.35 0.18 0.38 0.28 0.44 0.32 0.29 0.41 0.63 ** 0.14 0.08 0.49 *
SD 0.02 0.29 0.32 0.37 0.20 −0.25 −0.10 −0.08 0.20 0.16 −0.04 0.38 0.37 −0.18 −0.29 0.30
17 yr to now
Average 0.58 ** 0.03 0.37 0.38 0.41 0.32 0.60 ** 0.59 ** 0.56 * 0.60 ** 0.60 ** 0.24 0.48 * 0.11 0.09 0.30
SD 0.52 * −0.06 0.06 0.16 0.22 0.29 0.43 0.46 * 0.52 * 0.38 0.28 0.21 0.33 0.05 −0.11 −0.20
Current 0.41 −0.10 0.05 0.03 0.01 0.12 0.61 ** 0.58 ** 0.54 * 0.60 ** 0.37 0.00 0.30 0.21 0.16 0.11
Lifetime
Average 0.55 * 0.23 0.42 0.29 0.39 0.03 0.37 0.31 0.55 * 0.58 ** 0.33 0.23 0.58 * 0.12 0.12 0.38
SD 0.47 * 0.45 0.54 * 0.40 0.45 0.05 0.24 0.16 0.60 * 0.55 * 0.35 0.28 0.58 * 0.13 0.00 0.26
Highlighted rows compare childhood Phe measures with current Phe. To facilitate interpretation, positive correlations always indicate that high Phe was associated with a worse
performance. Thus, for IQ, digit span, Corsi span, and semantic fluency correlations were reversed. Significant measures are in bold. * = significant <0.05; ** significant <0.01.
Phe SD = Phe fluctuations.
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5. Discussion
There is a lack of studies which have assessed the behavioural effects of metabolic control
in individuals with PKU across countries with the same testing materials, comparing sensitivity.
This, instead, is important for establishing common PKU testing batteries and to accrue results across
centers for a rare disease. In spite of tremendous advances in our knowledge of PKU, we lack a
complete and reliable picture of cognitive outcomes in relation to metabolic controls at different ages,
which is crucial to establish the efficacy of new therapeutic interventions and to track developmental
trends which may demonstrate either cognitive improvements (by bridging developmental gaps) or
cognitive deterioration with age (due to abandoning the diet and/or accelerated aging). Our study
tested cognitive outcomes in two samples of Italian and English AwPKU closely matched for gender,
age, and education, using the same or closely matched materials.
5.1. Metabolic Control
Our results showed better metabolic control in the English than the Italian PKU sample. This could
be due to differences in clinical practice (the English group is one of the better controlled groups
described in the literature so far, which is likely due to the strong clinical advice received) or to cultural
differences in approaches to food across countries. While in Italy, the diet may be less protein-based than
in England, the stronger centrality of food in Italian society may make following a separate diet more
difficult. Our matched samples are small, and we do not have corroborative information indicating
whether following a PKU diet may be easier in England than in Italy. Nonetheless, our results point to
variability in metabolic control across groups, suggesting the need to explore possible, modulating
socio-cultural factors which could affect clinical management.
5.2. Cognitive Impairments
Our results showed similar patterns of cognitive outcomes and associations with metabolic
measures across the Italian and English groups. The Italian PKU participants performed worse
than the matched English PKU participants in a few tasks, consistent with their worse metabolic
control, but the overall level of impairment and the pattern of spared and impaired functions were
similar across groups. The results with an Italian sample confirm patterns of impaired and spared
functions previously reported with English participants [15]. They confirm substantial impairments in
the following:
- Speed of processing, at least, with tasks tapping visual attention (no other RT tasks were used),
confirming previous results [11,27], but good performance in the same tasks in terms of accuracy,
confirming that AwPKU are slow, but accurate.
- Executive functions in terms of flexibility and planning (TMT B and B–A and verbal fluency),
but no impairment in the WCST (see also Moyle et al. [49] for impairments in fluency, but no
impairments in the TMT B; see also Brumm et al. [25]; Smith et al. [50], for impairments in the
WCST; see Ris et al. [51], and Channon et al. [52], for impairments in a test similar to the WCST).
- Sustained attention (Rapid Visual Information Processing task; see also Channon et al. [52];
Bik-Multanowski et al., [53]; Jahja et al. [27]; Schmidt at al. [47]; Weglage et al. [9]).
- Visuo-motor coordination (marginal impairment in the peg-board task; see also Griffiths et al. [54];
Pietz et al. [55], but also Brumm et al. [25], for no impairment).
The Italian sample showed no impairments in verbal and visual short-term memory. Performance
was in fact better than the controls in the Corsi task, confirming the lack of impairment found in
Palermo et al., [15]. We have previously found a marginal impairment in digit span. The present results
are also consistent with Moyle et al., [49], who found no impairment in the working memory index of
the WAIS, and with Brumm et al. [25], who found no impairment in the forward digit span, but an
impairment with the backwards span (see also Jahja et al. [27] for deficits with increasing working
memory load).
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Finally, our results confirm no or marginal impairments in verbal and visual learning (for no
impairments in adults see also Channon et al. [52]; Moyle et al. [49]; for a review in children showing
mixed results see Janzen and Nguyen, [14]). These results support the idea that AwPKU perform better
when they can rely on learning and stored knowledge (see good performance in word spelling; better
word than nonword reading speed; and better digit span than nonword repetition; [15,16]).
When we have analysed patterns in visual search tasks, the Italian and English PKU samples
also showed similar results. Both groups were slower in conjunction than in feature search tasks and
showed increased delays with a number of distractors, especially in conjoined search and target absent
conditions. Compared to matched control, both Italian and English PKU samples showed delays
across tasks and conditions. However, in conjunction search, the English PKU group showed increased
delays with a number of distractors (a fanning out pattern), while the Italian PKU group showed stable
differences. In Romani et al. [16], we argued that two different types of difficulties may contribute to a
speed reduction in AwPKU: 1. Some specific processing difficulties such as a difficulty in allocating
visual attention; this will result in increasing differences from the control with number of distractors;
and 2. A general tendency to be more cautious/tentative in returning an answer which will result
in a fixed delay across conditions (a flat profile across conditions; a pattern that we have seen with
language tasks, see Romani et al., [16]). The Italian PKU sample is relatively small, and it is possible
that noise may have obliterated a fanning-out pattern in conjunction search. With this caveat, a stable
difference from controls, which is not affected by task difficulty, is more consistent with a delay in
making decisions than with processing difficulties.
Taken together, our results highlight how PKU does not impact cognition homogeneously.
Some functions are spared while others—like visuo-attentional speed—are severely impaired, showing
average Z scores between 1.2 and 1.5 from the control mean (and Z score SDs between 1.2 and 2.3),
which indicate that some people with PKU are at the extreme margin of the normal distribution.
To consider this variability is important for an accurate evaluation of outcomes in relation to current
and future treatment options. Our results also confirm the extreme variability in performance across
individual participants. In the Italian sample, 5 participants (26% of sample) showed a completely
normal cognitive performance.
Concerning the relationship between cognitive and metabolic measures, our Italian results
confirm extensive correlations between current and historical Phe measures and performance in
cognitive tasks. Previous studies have also found correlations between current and life-time Phe
levels and cognitive functions (see Brumm et al. [25] for correlations with backwards span, fluency,
WCST; Smith et al. [50] for a correlation with WCST; Moyle et al. [49] for correlations with TMT
and visual memory; Jahja et al. [27] for correlation with visual search tasks with a memory load;
see Romani et al. [5], and Hofman et al. [56], for a more detailed review of the literature). Other studies
have found differences in cognitive abilities between AwPKU with better versus worse metabolic
control. For example, Nardecchia et al. [26] found that patients with a worse metabolic control
had a lower IQ and worse performance at the WCST and at the Elithorn’s Perceptual Maze Test;
Bik-Multanowski et al. [53] found that patients with a worse metabolic control performed worse
in RVP, Spatial Span (SSP), Spatial Working Memory (SWM) and Stop Signal Task (SST; see also
Brumm et al. [25] and Palermo et al. [15] for results on more comprehensive sets of cognitive tasks).
Our results also confirm that both measures in terms of average Phe and Phe fluctuations correlate
with performance [57] and that there are interactions between type of function and age of metabolic
control. Some functions are more affected by historical Phe and others by current Phe. Speed in visual
attentional tasks is associated mainly with childhood Phe (both average and SD), while tasks tapping
visuo-motor coordination (digit-symbol, TMT), sustained attention and memory and learning are also
affected by current Phe [5,11].
Our results highlight the importance of using the right cognitive and metabolic measures to
assess outcomes. For example, a recent study by Bartus et al. [58] found no correlations between
Phe levels (current and life-time) and performance on three tasks of the computerized Cambridge
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Cognition Test (CANTAB)—Motor screening test, Spatial Working Memory test, and The Stoking of
Cambridge—in 47 AwPKU, nor any difference between groups with high vs. low Phe levels. However,
we also found no correlations when we used similar tasks with our Italian/English samples (motor
speed tapped by simple RT, visual WM tapped by Corsi span) or with larger English sample (the Tower
of Hanoi was not tested here; see Romani et al., [5]). This example shows the importance of using
both a comprehensive and an ad hoc set of tasks when assessing outcomes and their relationship with
metabolic variables. Failing to do so runs the risk of reaching the wrong conclusions regarding the
effects of relaxing metabolic control.
6. Conclusions
It is important to track the cognitive performance of people with PKU across the lifespan. This is
the first generation of early-treated AwPKU to move towards middle-age and people with PKU show
a tendency to progressively relax the diet with age [55,59–61]. However, we do not know what effects
prolonged high-levels of Phe may have on aging brains. Our results suggest that the effect of Phe on
the brain is different in childhood to early adulthood [6], but further interactions may be seen later
in life. Knowing which functions and relative tasks are most affected and most sensitive to Phe in
young adults with PKU provides an important base-line to compare outcomes across the life-span and
evaluate the effectiveness of treatment. Our study has contributed to an identification of sensitive tasks
by showing consistency across Italian and English samples in the patterns of impaired and spared
functions and similar patterns of correlations with metabolic measures and by replicating previous
findings. This provides preliminary evidence that common PKU batteries can be used across countries
to detect impairments with similar sensitivity. The similarity of the results across the Italian and English
PKU samples justified combining results in a single database in a follow-up study, giving us more
power to assess the interactions between types of metabolic variable (Phe average vs. Phe fluctuation),
age of metabolic control (childhood, adulthood, current) and type of cognitive functions, and more
power to assess the relationships between cognitive scores and adherence to metabolic guidelines [6].
Limitations
The main limitation of our study lies in the small sample of AwPKU tested in Italian. Although
this small sample is still sufficient to establish that our tasks are sensitive to metabolic control, larger
samples are necessary to compare individual correlations and replicate our preliminary findings
that qualitive patterns are the same across languages and nationalities. There was variability in the
correlation patterns shown by the Italian and English PKU samples. This is not surprising. The two
PKU samples were not matched for metabolic controls. More importantly, correlations are notoriously
unstable and have small samples, and this is a major stumbling block for research trying to establish
the relationship between metabolic controls and cognitive outcomes in people with PKU. However,
it is precisely this limitation that makes it important to establish that tasks are equally sensitive across
different nationalities so that results can be accrued. We hope that that our study will be followed by
further research to assess the sensitivity of the same tasks across languages in people with PKU.
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